Andre Pereira Fraga Figueiredo

Directeur/Membre du Conseil chez GENETETHER THERAPEUTICS INC.

Fortune : 64 077 $ au 31/05/2024

48 ans

7 relations

Consumer Services

Commercial Services

Health Technology

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
R. Geoffrey Sargent	M	70	GENETETHER THERAPEUTICS INC. GeneTether, Inc. GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California.	6 ans
Daren Graham	M	52	GENETETHER THERAPEUTICS INC. GeneTether, Inc. GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California.	6 ans
Garner William	M	58	GENETETHER THERAPEUTICS INC. GeneTether, Inc. GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California.	6 ans
Roland Boivin	M	57	GENETETHER THERAPEUTICS INC. GeneTether, Inc. GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California.	3 ans
Philip Jull	M	64	GENETETHER THERAPEUTICS INC. GeneTether, Inc. GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California.	3 ans
Jean Jen	F	37	GENETETHER THERAPEUTICS INC. GeneTether, Inc. GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California.	3 ans

Graphique Relationnel

Relation dans plusieurs entreprises

Anciennes relations

Nom	Sexe	Age	Sociétés liées	Collaboration
Peter Sampson	M	-	GENETETHER THERAPEUTICS INC.	2 ans

Statistiques

Pays	Relations	% du total
Canada	7	100,00%
Etats-Unis	6	85,71%

Age des relations

Actives

Passées

Homme

Femme

Administrateurs

Exécutifs

Provenance des relations